J&J, Merck, and Bristol Myers Squibb spend billions more on executives and stockholders than on R&D — Senate report points to greed and ‘patent thickets’ as key reasons for high prices ( arstechnica.com )
J&J, Merck, and Bristol Myers Squibb spend billions more on executives and stockholders than on R&D — Senate report points to greed and ‘patent thickets’ as key reasons for high prices::Senate report points to greed and "patent thickets" as key reasons for high prices.
![](https://mbin.grits.dev/media/cache/resolve/entry_thumb/a8/f2/a8f22f356636a5c45c513c4bb04570db101fb9c420097a339aa39a638a293093.jpg)